stoxline Quote Chart Rank Option Currency Glossary
  
Edwards Lifesciences Corporation (EW)
75.82  4.91 (6.92%)    02-12 16:00
Open: 74
High: 76
Volume: 9,352,924
  
Pre. Close: 70.91
Low: 73.89
Market Cap: 44,719(M)
Technical analysis
2025-02-12 4:44:36 PM
Short term     
Mid term     
Targets 6-month :  88.76 1-year :  103.68
Resists First :  76 Second :  88.76
Pivot price 71.43
Supports First :  71.19 Second :  68.23
MAs MA(5) :  71.63 MA(20) :  70.95
MA(100) :  70.16 MA(250) :  77.93
MACD MACD :  0.1 Signal :  -0.3
%K %D K(14,3) :  64.9 D(3) :  49.9
RSI RSI(14): 64.8
52-week High :  96.12 Low :  58.93
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ EW ] has closed Bollinger Bands are 15.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 76.06 - 76.42 76.42 - 76.75
Low: 72.97 - 73.38 73.38 - 73.77
Close: 75.14 - 75.79 75.79 - 76.41
Company Description

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Headline News

Wed, 12 Feb 2025
Edwards Lifesciences (NYSE:EW) Announces Quarterly Earnings Results - MarketBeat

Wed, 12 Feb 2025
Edwards Lifesciences (NYSE:EW) Releases Q1 2025 Earnings Guidance - MarketBeat

Wed, 12 Feb 2025
Edwards Lifesciences (NYSE:EW) Issues Quarterly Earnings Results - MarketBeat

Wed, 12 Feb 2025
Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength - Benzinga

Wed, 12 Feb 2025
Edwards Lifesciences Stock Outlook: Is Wall Street Bullish or Bearish? - Nasdaq

Wed, 12 Feb 2025
Is Edwards Lifesciences Corporation (EW) the Best Medical Device Stock to Buy? - Insider Monkey

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 590 (M)
Shares Float 584 (M)
Held by Insiders 0.9 (%)
Held by Institutions 87.5 (%)
Shares Short 9,040 (K)
Shares Short P.Month 7,300 (K)
Stock Financials
EPS 2.58
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 16.18
Profit Margin 65.8 %
Operating Margin 29.1 %
Return on Assets (ttm) 10.6 %
Return on Equity (ttm) 19.1 %
Qtrly Rev. Growth 8.8 %
Gross Profit (p.s.) 8.2
Sales Per Share 10.69
EBITDA (p.s.) 3.47
Qtrly Earnings Growth 716 %
Operating Cash Flow 806 (M)
Levered Free Cash Flow 1,790 (M)
Stock Valuations
PE Ratio 29.27
PEG Ratio 0
Price to Book value 4.68
Price to Sales 7.08
Price to Cash Flow 55.45
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android